Is MGRO.CN undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of MustGrow Biologics Corp (MGRO.CN) is -0.75 CAD. This MGRO.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.35 CAD, the upside of MustGrow Biologics Corp is -122.45%. This means that MGRO.CN is overvalued by 122.45%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.75 - -0.75 | -0.75 | -122.45% |
| P/E | (0.34) - (0.36) | (0.36) | -110.9% |
| DDM - Stable | (1.73) - (15.67) | (8.70) | -359.7% |
| DDM - Multi | (1.57) - (11.54) | (2.81) | -183.8% |
| Market Cap (mil) | 123.97 |
| Beta | 1.07 |
| Outstanding shares (mil) | 37.01 |
| Enterprise Value (mil) | 119.72 |
| Market risk premium | 5.50% |
| Cost of Equity | 7.48% |
| Cost of Debt | 5.00% |
| WACC | 7.46% |